Making Sense of the Science of WM sets out a framework for patients to understand the basic genetic concepts behind the mutations that are important in WM, to appreciate the ways in which these mutations impact the signaling systems that control the behavior of WM cells, and to recognize how these mutations are changing the landscape of therapies for WM.

About the presenter:
Dr. Zachary Hunter, Ph.D., is an Instructor of Medicine at Harvard Medical School working at the Bing Center for Waldenstrom's Macroglobulinemia at the Dana-Farber Cancer Institute under Dr. Steven Treon. There he coordinates the next generation sequencing and bioinformatic efforts for the group. He holds a B.A. in mathematics from Haverford College and a Ph.D. in Pathology from Boston University. He has co-authored over 90 papers on WM, including the initial whole genome analysis describing the MYD88 and CXCR4 mutations. His is the recipient of the Robert A. Kyle Award, the American Society of Hematology Scholar Award, and recently received an IWMF-LLS Strategic Roadmap grant to study the dysregulation of gene transcription based on mutational patterns in WM. His current research interests include familial predisposition, clonal evolution, and signaling network analysis.

This video was broadcast as part of the 2020 IWMF Global Educational Webinar, September 9, 2020.